GABAergic System Dysfunction in Autism Spectrum Disorders
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Autism spectrum disorder (ASD) refers to a series of neurodevelopmental diseases characterized by two hallmark symptoms, social communication deficits and repetitive behaviors. Gamma-aminobutyric acid (GABA) is one of the most important inhibitory neurotransmitters in the central nervous system (CNS). GABAergic inhibitory neurotransmission is critical for the regulation of brain rhythm and spontaneous neuronal activities during neurodevelopment. Genetic evidence has identified some variations of genes associated with the GABA system, indicating an abnormal excitatory/inhibitory (E/I) neurotransmission ratio implicated in the pathogenesis of ASD. However, the specific molecular mechanism by which GABA and GABAergic synaptic transmission affect ASD remains unclear. Transgenic technology enables translating genetic variations into rodent models to further investigate the structural and functional synaptic dysregulation related to ASD. In this review, we summarized evidence from human neuroimaging, postmortem, and genetic and pharmacological studies, and put emphasis on the GABAergic synaptic dysregulation and consequent E/I imbalance. We attempt to illuminate the pathophysiological role of structural and functional synaptic dysregulation in ASD and provide insights for future investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990
Excitatory actions of gaba during development: the nature of the nurture
Ben-Ari, Y. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn920 · Cited by 2,448 · cited 1×
“GABA functions as an excitatory neurotransmitter during embryonic development (Ben-Ari, 2002).”
BackgroundGenetic Heritability and Shared Environmental Factors Among Twin Pairs With Autism
Hallmayer, J. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.76 · Cited by 1,970 · cited 1×
“ASD-related Nlgn4 mutations can alter the compositions of hippocampal perisomatic inhibitory synapses and impaired the synchronized oscillatory activity whichmight be implicated in the cognitive dysfunction of ASD (Hammer et al., 2015).”
BackgroundAutism and Abnormal Development of Brain Connectivity: Figure 1.
Belmonte, M. K., Allen, G., Beckel-Mitchener, A., Boulanger, L. M., Carper, R. A., & Webb, S. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3340-04.2004 · Cited by 1,217
Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes
Chao, H.-T., Chen, H., Samaco, R. C., Xue, M., Chahrour, M., Yoo, J., Neul, J. L., Gong, S., Lu, H.-C., Heintz, N., et al. (2010) · Nature · doi:10.1038/nature09582 · Cited by 1,168
Peñagarikano, O., Abrahams, B. S., Herman, E. I., Winden, K. D., Gdalyahu, A., Dong, H., Sonnenblick, L. I., Gruver, R., Almajano, J., Bragin, A., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.040 · Cited by 1,075 · cited 2×
“Human and animal studies have reported that mutations in CNTNAP2 cause a syndrome form of ASD with significant behavioral defects in social interaction and stereotypes (Peñagarikano et al., 2011).”
BackgroundDuman, R. S., Sanacora, G., & Krystal, J. H. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.013 · Cited by 1,026
Autism: cognitive deficit or cognitive style?
Happé, F. (1999) · Trends in Cognitive Sciences · doi:10.1016/s1364-6613(99)01318-2 · Cited by 957
Autistic-like behaviour in Scn1a+/− mice and rescue by enhanced GABA-mediated neurotransmission
Han, S., Tai, C., Westenbroek, R. E., Yu, F. H., Cheah, C. S., Potter, G. B., Rubenstein, J. L., Scheuer, T., de la Iglesia, H. O., & Catterall, W. A. (2012) · Nature · doi:10.1038/nature11356 · Cited by 643
Prenatal Poly(I:C) Exposure and Other Developmental Immune Activation Models in Rodent Systems
Meyer, U. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.07.011 · Cited by 626 · cited 1×
“Another widely studied pharmacological model of ASD is the MIA model, which refers to immune activation by immunogen administration during pregnancy, such as lipopolysaccharide (LPS) or polyinosinic–polycytidylic acid (poly (I:C)) (Meyer, 2014; Haddad et al., 2020).”
BackgroundCommon circuit defect of excitatory-inhibitory balance in mouse models of autism
Gogolla, N., LeBlanc, J. J., Quast, K. B., Südhof, T. C., Fagiolini, M., & Hensch, T. K. (2009) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-009-9023-x · Cited by 610
Oxytocin-Mediated GABA Inhibition During Delivery Attenuates Autism Pathogenesis in Rodent Offspring
Tyzio, R., Nardou, R., Ferrari, D. C., Tsintsadze, T., Shahrokhi, A., Eftekhari, S., Khalilov, I., Tsintsadze, V., Brouchoud, C., Chazal, G., et al. (2014) · Science · doi:10.1126/science.1247190 · Cited by 601
The Shank family of scaffold proteins
Sheng, M., & Kim, E. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.11.1851 · Cited by 578
Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments
Krystal, J. H., Sanacora, G., Blumberg, H., Anand, A., Charney, D. S., Marek, G., Epperson, C. N., Goddard, A., & Mason, G. F. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001021 · Cited by 553
GABAA Receptor Downregulation in Brains of Subjects with Autism
Fatemi, S. H., Reutiman, T. J., Folsom, T. D., & Thuras, P. D. (2009) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-008-0646-7 · Cited by 439
Berry-Kravis, E. M., Hessl, D., Rathmell, B., Zarevics, P., Cherubini, M., Walton-Bowen, K., Mu, Y., Nguyen, D. V., Gonzalez-Heydrich, J., Wang, P. P., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004214 · Cited by 328
A synaptic perspective of fragile X syndrome and autism spectrum Disorders.
Bagni, C., & Zukin, R. S. (2019) · Neuron · doi:10.1016/j.neuron.2019.02.041 · Cited by 326 · cited 1×
“FMRP can affect synaptic phenotype as an mRNAbinding transitional suppressor via modulating the synthesis of synaptic proteins which implicated in synaptic transmission (Bagni and Zukin, 2019).”
BackgroundBlatt, G. J., Fitzgerald, C. M., Guptill, J. T., Booker, A. B., Kemper, T. L., & Bauman, M. L. (2001) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1013238809666 · Cited by 322 · cited 2×
“Further evidence found that reduced [(3)H]flunitrazepamlabeled benzodiazepines(BDZ) sites in the autistic hippocampus were due to a decrease in the binding site number or number of receptors but not due to the binding affinity (Blatt et al., 2001; Guptill et al., 2007; Lawrence et al., 2010).”
BackgroundRudolph, U., & Möhler, H. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135947 · Cited by 319
Decreased expression of the GABAA receptor in fragile X syndrome
D'Hulst, C., De Geest, N., Reeve, S. P., Van Dam, D., De Deyn, P. P., Hassan, B. A., & Kooy, R. F. (2006) · Brain Research · doi:10.1016/j.brainres.2006.08.115 · Cited by 318 · cited 1×
“However, GAD65 and GAD67 expression levels were inversely increased in Fragile Xmice (D’Hulst et al., 2006; Adusei et al., 2010).”
BackgroundOlmos-Serrano, J. L., Paluszkiewicz, S. M., Martin, B. S., Kaufmann, W. E., Corbin, J. G., & Huntsman, M. M. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1714-10.2010 · Cited by 309
Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling
Földy, C., Malenka, R. C., & Südhof, T. C. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.036 · Cited by 287
Filice, F., Vörckel, K. J., Sungur, A. Ö., Wöhr, M., & Schwaller, B. (2016) · Molecular Brain · doi:10.1186/s13041-016-0192-8 · Cited by 240
Harada, M., Taki, M. M., Nose, A., Kubo, H., Mori, K., Nishitani, H., & Matsuda, T. (2011) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-010-1065-0 · Cited by 231
Expression of GABAB Receptors Is Altered in Brains of Subjects with Autism
Fatemi, S. H., Folsom, T. D., Reutiman, T. J., & Thuras, P. D. (2009) · The Cerebellum · doi:10.1007/s12311-008-0075-3 · Cited by 227
Silverman, J. L., Pride, M. C., Hayes, J. E., Puhger, K. R., Butler-Struben, H. M., Baker, S., & Crawley, J. N. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.66 · Cited by 215 · cited 1×
“The most widely studied GABA modulator is baclofen, a GABAB receptor agonist, which was reported to reverse social approach deficits and repetitive behaviors of BTBR T+ Itpr3tf/J (BTBR) mice, and also reduced the stereotyped jumping in C58/J (C58), another ASD model (Silverman et al., 2015).”
BackgroundFatemi, S. H., Reutiman, T. J., Folsom, T. D., Rooney, R. J., Patel, D. H., & Thuras, P. D. (2010) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-009-0924-z · Cited by 182
Abnormal Striatal GABA Transmission in the Mouse Model for the Fragile X Syndrome
Centonze, D., Rossi, S., Mercaldo, V., Napoli, I., Ciotti, M. T., De Chiara, V., Musella, A., Prosperetti, C., Calabresi, P., Bernardi, G., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.008 · Cited by 171 · cited 1×
“found that Fmr1 KO mice have fewer GABAergic synapses whereas higher levels of spontaneous GABA inhibitory transmission in the striatum (Centonze et al., 2008).”
BackgroundLemonnier, E., & Ben‐Ari, Y. (2010) · Acta Paediatrica · doi:10.1111/j.1651-2227.2010.01933.x · Cited by 153 · cited 1×
“A study with a small sample found that treatment with bumetanide decreased the autistic behaviors in autistic infants (Lemonnier and Ben-Ari, 2010).”
BackgroundEarly developmental alterations in GABAergic protein expression in fragile X knockout mice
Adusei, D. C., Pacey, L. K. K., Chen, D., & Hampson, D. R. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.05.002 · Cited by 139
Pacey, L. K. K., Heximer, S. P., & Hampson, D. R. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.056127 · Cited by 133 · cited 1×
“Treatment with GABA-B receptor antagonist is prone to induce seizures in Fmr1/RGS4 double-knockout mice than wild-type mice, whereas agonist of GABA-B baclofen can inhibit seizures in Fmr1/RGS4 double-knockout mice (Pacey et al., 2009).”
BackgroundHadjikhani, N., Zürcher, N. R., Rogier, O., Ruest, T., Hippolyte, L., Ben-Ari, Y., & Lemonnier, E. (2015) · Autism · doi:10.1177/1362361313514141 · Cited by 129
Loss of MeCP2 From Forebrain Excitatory Neurons Leads to Cortical Hyperexcitation and Seizures
Zhang, W., Peterson, M., Beyer, B., Frankel, W. N., & Zhang, Z.-W. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.4900-12.2014 · Cited by 125
Complex epigenetic regulation of Engrailed-2 (EN-2) homeobox gene in the autism cerebellum
James, S. J., Shpyleva, S., Melnyk, S., Pavliv, O., & Pogribny, I. P. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.8 · Cited by 100 · cited 1×
“…in postnatal GABAergic neurons of the mouse hippocampus and cerebral cortex, and it was found that persistant high expression of EN2 during the prenatal and early postnatal period contributes to autism by affecting the maturation of Purkinje cell (PCs) in the cerebellum (James et al., 2013, 2014).”
BackgroundBumetanide for autism: more eye contact, less amygdala activation
Hadjikhani, N., Åsberg Johnels, J., Lassalle, A., Zürcher, N. R., Hippolyte, L., Gillberg, C., Lemonnier, E., & Ben-Ari, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-21958-x · Cited by 90
Fatemi, S. H., & Folsom, T. D. (2011) · Molecular Autism · doi:10.1186/2040-2392-2-6 · Cited by 84
James, S. J., Shpyleva, S., Melnyk, S., Pavliv, O., & Pogribny, I. P. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.87 · Cited by 79
Metabolite alterations in autistic children: a 1H MR spectroscopy study
Kubas, B., Kułak, W., Sobaniec, W., Tarasow, E., Łebkowska, U., & Walecki, J. (2012) · Advances in Medical Sciences · doi:10.2478/v10039-012-0014-x · Cited by 74 · cited 3×
“Recently, amounts of evidence using magnetic resonance spectroscopy (MRS) found that the lower ratio of GABA/ glutamate (Harada et al., 2011; Kubas et al., 2012; Drenthen et al., 2016; Ajram et al., 2017), N-acetylaspartate/creatine, GABA/creatine, and glutamate/creatine (Kubas et al.”
BackgroundRegulation of molecular pathways in the Fragile X Syndrome: insights into Autism Spectrum Disorders
De Rubeis, S., & Bagni, C. (2011) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-011-9087-2 · Cited by 73
Deletion of Fmr1 alters function and synaptic inputs in the auditory brainstem
Rotschafer, S. E., Marshak, S., & Cramer, K. S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0117266 · Cited by 72
Genome-wide copy number variation analysis in a Chinese autism spectrum disorder cohort
Guo, H., Peng, Y., Hu, Z., Li, Y., Xun, G., Ou, J., Sun, L., Xiong, Z., Liu, Y., Wang, T., et al. (2017) · Scientific Reports · doi:10.1038/srep44155 · Cited by 71
Self-citationHammer, M., Krueger-Burg, D., Tuffy, L. P., Cooper, B. H., Taschenberger, H., Goswami, S. P., Ehrenreich, H., Jonas, P., Varoqueaux, F., Rhee, J.-S., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.011 · Cited by 66
Cortical control of aggression: GABA signalling in the anterior cingulate cortex
Jager, A., Amiri, H., Bielczyk, N., van Heukelum, S., Heerschap, A., Aschrafi, A., Poelmans, G., Buitelaar, J. K., Kozicz, T., & Glennon, J. C. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.12.007 · Cited by 60
Postnatal behavioral and inflammatory alterations in female pups prenatally exposed to valproic acid
Kazlauskas, N., Campolongo, M., Lucchina, L., Zappala, C., & Depino, A. M. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.06.001 · Cited by 56
Bonnet-Brilhault, F., Alirol, S., Blanc, R., Bazaud, S., Marouillat, S., Thépault, R.-A., Andres, C. R., Lemonnier, É., Barthélémy, C., Raynaud, M., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.75 · Cited by 41 · cited 3×
“15q11–q13 site contains coding regions of specific subunits of GABA-AR, including GABRB3, GABRA5, and GABRG3, which are strongly implicated in the pathogenesis of autism (Delahanty et al., 2011; Bonnet-Brilhault et al., 2016; Guo et al., 2017).”
BackgroundHeterogeneous association between engrailed‐2 and autism in the CPEA network
Brune, C. W., Korvatska, E., Allen‐Brady, K., Cook, E. H., Dawson, G., Devlin, B., Estes, A., Hennelly, M., Hyman, S. L., McMahon, W. M., et al. (2008) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30585 · Cited by 40
Bumetanide for autism spectrum disorder in children: a review of randomized controlled trials
James, B. J., Gales, M. A., & Gales, B. J. (2019) · Annals of Pharmacotherapy · doi:10.1177/1060028018817304 · Cited by 35
Cited by
Gut liver brain axis in diseases: the implications for therapeutic interventions
Yan, M., Man, S., Sun, B., Ma, L., Guo, L., Huang, L., & Gao, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01673-4 · Cited by 287
GABA release from astrocytes in health and disease.
Kilb, W., & Kirischuk, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415859 · Cited by 66
Metadata
- Authors
- Zhao, H., Mao, X., Zhu, C., Zou, X., Peng, F., Yang, W., Li, B., Li, G., Ge, T., & Cui, R.
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2022-02-07
- Volume
- 9
- Pages
- 781327-781327
- ISSN
- 2296-634X (ISSN-L)
- OpenAlex
- W4210614123
- Cited by
- 169
- References
- 47
- FWCI
- 18.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.